http://www.eurekalert.org/pub_releas...-uhb022813.php

this is what got my attn.

In a parallel study published in the journal in early February, Dr. Goldman and his team reported that they could efficiently generate glial progenitor cells from human skin cells reprogrammed into induced pluripotent cells. As a result, the researchers can now establish glial progenitor cells on a patient-specific basis from individuals with brain diseases, including a number of neuropsychiatric and neurological disorders that are relatively specific to humans. By implanting these cells into mice as they did in this most recent study, the investigators can assess the role of glial cells in these disorders, as well as test different treatment strategies that target abnormal glial function. They are currently carrying out these experiments with cells from patients with schizophrenia and Huntington's disease.